एपीए उद्धरण

Maekawa, T., & Hajishengallis, G. (2014). Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss.

शिकागो स्टाइल उद्धरण

Maekawa, Tomoki, और George Hajishengallis. Topical Treatment With Probiotic Lactobacillus Brevis CD2 Inhibits Experimental Periodontal Inflammation and Bone Loss. 2014.

एमएलए उद्धरण

Maekawa, Tomoki, और George Hajishengallis. Topical Treatment With Probiotic Lactobacillus Brevis CD2 Inhibits Experimental Periodontal Inflammation and Bone Loss. 2014.